middle.news
How ResMed’s $5.15B Revenue and VirtuOx Deal Signal Digital Health’s Future
8:31am on Monday 11th of August, 2025 AEST
•
Healthcare
Read Story
How ResMed’s $5.15B Revenue and VirtuOx Deal Signal Digital Health’s Future
8:31am on Monday 11th of August, 2025 AEST
Key Points
10% revenue growth to $5.15 billion in fiscal 2025
Net income surged 37% to $1.4 billion
Acquisition of VirtuOx enhances in-home diagnostic testing
Focus on AI integration and digital health innovation
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Resmed (ASX:RMD)
OPEN ARTICLE